The way I am understanding this,Biocentric Global will aquire the assets and IP of BEHL. Since our local bashers insist BEHL has no assets then the only thing Biocentric Global will get it the know-how of a PBR (IP) and some office equipment(assets).
That being said, then BEHL will continue selling PBRs and getting service contracts. BEHL will be a subsidiary of Biocentric Global.
That would mean that Biocentric Global will be in a "different" business. I would think that would have something to do with the medical/cosmetic end of things.
Since we keep our shares of BEHL and it continuse to do business then our "bonus" is all based on what the new company's business plan is.
If I am right in all this then the bonus is an instant double up.
Can anyone tell me if I am correct in this or tell me where I misunderstood
Market Data 
Markets 
AI
